Precision-Designed 3βHSD1 Inhibitors Offer Hope for Prostate Cancer Therapy
Fast Summary Study published in Proceedings of the National Academy of sciences, Volume 122, Issue 26, July 2025. Focuses on steroidogenic enzyme 3β-hydroxysteroid dehydrogenase type 1 (3βHSD1), which is linked